Know Cancer

or
forgot password


N/A
21 Years
70 Years
Not Enrolling
Both
Neoplasms

Thank you

Trial Information


Inclusion Criteria:



- Male or female, age 21 to 70 years old.

- Patient undergoing with anti-neoplastic agent(s) known to have genotoxic activity
(e.g., cyclophosphamide, 5-FU, cisplatin, Ara-C.

- X-irradiation may be considered, so long as a substantial fraction of red marrow is
exposed (e.g., femur or chest/trunk region);

- treatment could be ongoing therapy or initial therapy.

Type of Study:

Observational

Study Design:

Observational Model: Defined Population, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Yuhchyau Chen, MD, Ph.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

Universtiy of Rochester, Dept of Radiation Oncology

Authority:

United States: Institutional Review Board

Study ID:

URCC 1702

NCT ID:

NCT00178308

Start Date:

Completion Date:

Related Keywords:

  • Neoplasms
  • Neoplasms

Name

Location

University of RochesterRochester, New York  14642